Furie RA - Search Results

1

Abetimus sodium for renal flare in systemic lupus erythematosus: results of a randomized, controlled phase III trial.

Cardiel MH, Tumlin JA, Furie RA, Wallace DJ, Joh T, Linnik MD; LJP 394-90-09 Investigator Consortium. Cardiel MH, et al. Among authors: furie ra. Arthritis Rheum. 2008 Aug;58(8):2470-80. doi: 10.1002/art.23673. Arthritis Rheum. 2008. PMID: 18668592 Free article. Clinical Trial.

2

Functional asplenia in systemic lupus erythematosus.

Piliero P, Furie R. Piliero P, et al. Semin Arthritis Rheum. 1990 Dec;20(3):185-9. doi: 10.1016/0049-0172(90)90059-o. Semin Arthritis Rheum. 1990. PMID: 2287943 Free article. Review.

3

Tendon rupture in systemic lupus erythematosus.

Furie RA, Chartash EK. Furie RA, et al. Semin Arthritis Rheum. 1988 Nov;18(2):127-33. doi: 10.1016/0049-0172(88)90005-4. Semin Arthritis Rheum. 1988. PMID: 3064304 Review.

4

Systemic lupus erythematosus complicated by thrombotic microangiopathy.

Jain R, Chartash E, Susin M, Furie R. Jain R, et al. Semin Arthritis Rheum. 1994 Dec;24(3):173-82. doi: 10.1016/0049-0172(94)90073-6. Semin Arthritis Rheum. 1994. PMID: 7899875 Review.

5

Pre-treatment affinity for LJP 394 influences pharmacodynamic response in lupus patients.

McNeeley PA, Iverson GM, Furie RA, Cash JM, Cronin ME, Katz RS, Weisman MH, Aranow C, Linnik MD. McNeeley PA, et al. Among authors: furie ra. Lupus. 2001;10(8):526-32. doi: 10.1191/096120301701549642. Lupus. 2001. PMID: 11530993 Clinical Trial.

6

The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus.

Huang W, Sinha J, Newman J, Reddy B, Budhai L, Furie R, Vaishnaw A, Davidson A. Huang W, et al. Arthritis Rheum. 2002 Jun;46(6):1554-62. doi: 10.1002/art.10273. Arthritis Rheum. 2002. PMID: 12115186 Free article.

7

LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study.

Alarcón-Segovia D, Tumlin JA, Furie RA, McKay JD, Cardiel MH, Strand V, Bagin RG, Linnik MD, Hepburn B; LJP 394 Investigator Consortium. Alarcón-Segovia D, et al. Among authors: furie ra. Arthritis Rheum. 2003 Feb;48(2):442-54. doi: 10.1002/art.10763. Arthritis Rheum. 2003. PMID: 12571854 Free article. Clinical Trial.

8

A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis.

Boumpas DT, Furie R, Manzi S, Illei GG, Wallace DJ, Balow JE, Vaishnaw A; BG9588 Lupus Nephritis Trial Group. Boumpas DT, et al. Arthritis Rheum. 2003 Mar;48(3):719-27. doi: 10.1002/art.10856. Arthritis Rheum. 2003. PMID: 12632425 Free article. Clinical Trial.

9

Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placebo.

Strand V, Aranow C, Cardiel MH, Alarcón-Segovia D, Furie R, Sherrer Y, Tumlin J, Wallace DJ, Crawford B; LJP 394 Investigator Consortium. Strand V, et al. Lupus. 2003;12(9):677-86. doi: 10.1191/0961203303lu440oa. Lupus. 2003. PMID: 14514130 Clinical Trial.

10

Abetimus sodium (riquent) for the prevention of nephritic flares in patients with systemic lupus erythematosus.

Furie R. Furie R. Rheum Dis Clin North Am. 2006 Feb;32(1):149-56, x. doi: 10.1016/j.rdc.2005.11.001. Rheum Dis Clin North Am. 2006. PMID: 16504827 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

182 results

Search Page